Notice Information
Notice Title
Consultancy Services relating to the design, validation and Qualification of Clean Rooms within Gene Therapy Innovation Manufacturing Centre
Notice Description
The University of Sheffield (UoS) is establishing a new 'Gene Therapy Innovation Manufacturing Centre' (GTIMC) to advance scientific discoveries into life-changing treatments for patients with life threatening diseases. The Sheffield GTIMC will be one of three cutting edge hubs in the UK dedicated to advancing the clinical development of new genetic treatments. This facility is due to open in the Summer of 2022 and further details can be found at the following link:- https://www.sheffield.ac.uk/news/new-gene-therapy-innovation-centre-advance-scientific-discoveries-life-changing-treatments The services to be procured include the Qualification and Validation stages of the build completion of the Research and Development facilities including all Quality Control, Clean Room areas in grades C and grade D environments including obtaining full MHRA Licence.
Lot Information
Lot 1
Services are required for a number of tasks during the Qualification and Validation stages of the build completion of the Research and Development facilities including all Quality Control, Clean Room areas in grades C and grade D environments in addition to all process areas across the site and supporting site operations such as major infrastructure and support services such as logistics in addition to other areas. These works are to cover the following areas / requirements: Qualification Requirement Matrix prepared to track Validation Lifecycle and to support; MHRA Audit. Used on previous MHRA audits and proved effective; Validation Assessment, User Requirement Specifications, Validation Plan, Design Document Reviews; Vendor Document Reviews, Factory Acceptance Tests Site Acceptance Tests (Commissioning); COTS Installation/Operational Qualification Protocol, Installation Qualification Protocol; Thermal Mapping Protocol (Empty and Loaded), Operational Qualification Protocol; Performance Qualification Protocol, Validation Summary Reports; It is envisaged that the majority of documentation preparation will be carried out remotely from the new build site, however, close working relationships will be required with attendance at site meetings for all aspects of the build and clean room fit outs will be required therefore an estimate of 50% site attendance is anticipated. It will be a requirement that the provider will regularly visit site throughout the construction period to ensure that the build is being documented to a suitable standard to allow for information leveraging into qualification. These visits will also be to ensure that the MHRA are suitably informed throughout all stages of the construction period. Attendance by the provider and being that professional capacity for all engagement with the MHRA will be a major requirement and throughout the Licence application process and to assist the client in this application process through to successfully licence being granted. Major recent experience is therefore a pre-request in interaction with the MHRA in the field of both Cell and Gene Therapy, Clean Room Manufacturing, Covid-19 Vaccine Response and recent demonstrated deployment / experience within Cell and Gene Therapy is of the highest importance. As part of the process of validation and qualification, down stream training will be required to be delivered to allow for periodic validation of clean rooms areas by incumbent UoS GTIMC and UoS Estates and Facilities staff. The project has extremely aggressive timelines with build construction due for completion in July 2022 and therefore standing up of this service will be required to be in place during the early stages of February 2022.
Procurement Information
The University of Sheffield signed an agreement with Cell and Gene Therapy Catapult (CGT Catapult) to tech transfer the Catapult AAV (Adeno-Associated Virus) manufacturing platform to Gene Therapy Innovation and Manufacturing Centre' (GTIMC). This task is one of the milestones under the funding award supporting the establishment of the GTIMC in Sheffield. The milestone must be completed within 12 months of the start of the GTIMC Project, i.e. by end July 2022. Any delay in the tech transfer will also impact on the milestone related to MHRA accreditation of GTIMC due by end Q4 2022. The GTIMC and University of Sheffield will jointly acquire a technology license from CGT Catapult to be able to use their AAV manufacturing platform. This platform was established and optimised based on the processes developed using the proposed list of equipment. A single source is therefore proposed to formalise the solution provided by Complete Technical Solutions Ltd for the following reasons: - Significant recent (within the previous 6 months) experience is therefore a pre-request in interaction with the MHRA in the field of both Cell and Gene Therapy, Clean Room Manufacturing, Covid-19 Vaccine Response and recent demonstrated deployment / experience within Cell and Gene Therapy is of the highest importance. To increase the U.K. capacity for GMP clinical vector manufacturing using the Catapult process to allow for expansion of U.K. skills and training within the GTIMC space and increase partnerships with other academia which will create a fertile ecosystem for innovation and research excellence in this field across academia.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-030f50
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/005165-2022
- Current Stage
- Award
- All Stages
- Tender, Award
Procurement Classification
- Notice Type
- Tender Notice
- Procurement Type
- Standard
- Procurement Category
- Services
- Procurement Method
- Limited
- Procurement Method Details
- Award procedure without prior publication of a call for competition
- Tender Suitability
- Not specified
- Awardee Scale
- SME
Common Procurement Vocabulary (CPV)
- CPV Divisions
71 - Architectural, construction, engineering and inspection services
-
- CPV Codes
71530000 - Construction consultancy services
Notice Value(s)
- Tender Value
- Not specified
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- £370,000 £100K-£500K
Notice Dates
- Publication Date
- 24 Feb 20223 years ago
- Submission Deadline
- Not specified
- Future Notice Date
- Not specified
- Award Date
- 16 Jan 20224 years ago
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Cancelled
- Awards Status
- Active
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- UNIVERSITY OF SHEFFIELD
- Contact Name
- Jamie Shaw
- Contact Email
- jamie.shaw@sheffield.ac.uk
- Contact Phone
- +44 1142221516
Buyer Location
- Locality
- SHEFFIELD
- Postcode
- S10 2TN
- Post Town
- Sheffield
- Country
- England
-
- Major Region (ITL 1)
- TLE Yorkshire and The Humber
- Basic Region (ITL 2)
- TLE3 South Yorkshire
- Small Region (ITL 3)
- TLE32 Sheffield
- Delivery Location
- TLE32 Sheffield
-
- Local Authority
- Sheffield
- Electoral Ward
- Broomhill and Sharrow Vale
- Westminster Constituency
- Sheffield Central
Further Information
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-030f50-2022-02-24T14:19:58Z",
"date": "2022-02-24T14:19:58Z",
"ocid": "ocds-h6vhtk-030f50",
"initiationType": "tender",
"tender": {
"id": "ocds-h6vhtk-030f50",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "Consultancy Services relating to the design, validation and Qualification of Clean Rooms within Gene Therapy Innovation Manufacturing Centre",
"status": "complete",
"classification": {
"scheme": "CPV",
"id": "71530000",
"description": "Construction consultancy services"
},
"mainProcurementCategory": "services",
"description": "The University of Sheffield (UoS) is establishing a new 'Gene Therapy Innovation Manufacturing Centre' (GTIMC) to advance scientific discoveries into life-changing treatments for patients with life threatening diseases. The Sheffield GTIMC will be one of three cutting edge hubs in the UK dedicated to advancing the clinical development of new genetic treatments. This facility is due to open in the Summer of 2022 and further details can be found at the following link:- https://www.sheffield.ac.uk/news/new-gene-therapy-innovation-centre-advance-scientific-discoveries-life-changing-treatments The services to be procured include the Qualification and Validation stages of the build completion of the Research and Development facilities including all Quality Control, Clean Room areas in grades C and grade D environments including obtaining full MHRA Licence.",
"lots": [
{
"id": "1",
"description": "Services are required for a number of tasks during the Qualification and Validation stages of the build completion of the Research and Development facilities including all Quality Control, Clean Room areas in grades C and grade D environments in addition to all process areas across the site and supporting site operations such as major infrastructure and support services such as logistics in addition to other areas. These works are to cover the following areas / requirements: Qualification Requirement Matrix prepared to track Validation Lifecycle and to support; MHRA Audit. Used on previous MHRA audits and proved effective; Validation Assessment, User Requirement Specifications, Validation Plan, Design Document Reviews; Vendor Document Reviews, Factory Acceptance Tests Site Acceptance Tests (Commissioning); COTS Installation/Operational Qualification Protocol, Installation Qualification Protocol; Thermal Mapping Protocol (Empty and Loaded), Operational Qualification Protocol; Performance Qualification Protocol, Validation Summary Reports; It is envisaged that the majority of documentation preparation will be carried out remotely from the new build site, however, close working relationships will be required with attendance at site meetings for all aspects of the build and clean room fit outs will be required therefore an estimate of 50% site attendance is anticipated. It will be a requirement that the provider will regularly visit site throughout the construction period to ensure that the build is being documented to a suitable standard to allow for information leveraging into qualification. These visits will also be to ensure that the MHRA are suitably informed throughout all stages of the construction period. Attendance by the provider and being that professional capacity for all engagement with the MHRA will be a major requirement and throughout the Licence application process and to assist the client in this application process through to successfully licence being granted. Major recent experience is therefore a pre-request in interaction with the MHRA in the field of both Cell and Gene Therapy, Clean Room Manufacturing, Covid-19 Vaccine Response and recent demonstrated deployment / experience within Cell and Gene Therapy is of the highest importance. As part of the process of validation and qualification, down stream training will be required to be delivered to allow for periodic validation of clean rooms areas by incumbent UoS GTIMC and UoS Estates and Facilities staff. The project has extremely aggressive timelines with build construction due for completion in July 2022 and therefore standing up of this service will be required to be in place during the early stages of February 2022.",
"hasOptions": false,
"awardCriteria": {
"criteria": [
{
"type": "price"
}
]
},
"status": "cancelled"
}
],
"items": [
{
"id": "1",
"deliveryAddresses": [
{
"region": "UKE32"
},
{
"region": "UKE32"
},
{
"region": "UKE32"
}
],
"deliveryLocation": {
"description": "Gene Therapy Innovation and Manufacturing Centre, Faculty of Medicine Dentistry and Health, The University of Sheffield"
},
"relatedLot": "1"
}
],
"procurementMethod": "limited",
"procurementMethodDetails": "Award procedure without prior publication of a call for competition",
"coveredBy": [
"GPA"
],
"procurementMethodRationaleClassifications": [
{
"scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
"id": "D_TECHNICAL",
"description": "The works, supplies or services can be provided only by a particular economic operator due to absence of competition for technical reasons"
}
],
"procurementMethodRationale": "The University of Sheffield signed an agreement with Cell and Gene Therapy Catapult (CGT Catapult) to tech transfer the Catapult AAV (Adeno-Associated Virus) manufacturing platform to Gene Therapy Innovation and Manufacturing Centre' (GTIMC). This task is one of the milestones under the funding award supporting the establishment of the GTIMC in Sheffield. The milestone must be completed within 12 months of the start of the GTIMC Project, i.e. by end July 2022. Any delay in the tech transfer will also impact on the milestone related to MHRA accreditation of GTIMC due by end Q4 2022. The GTIMC and University of Sheffield will jointly acquire a technology license from CGT Catapult to be able to use their AAV manufacturing platform. This platform was established and optimised based on the processes developed using the proposed list of equipment. A single source is therefore proposed to formalise the solution provided by Complete Technical Solutions Ltd for the following reasons: - Significant recent (within the previous 6 months) experience is therefore a pre-request in interaction with the MHRA in the field of both Cell and Gene Therapy, Clean Room Manufacturing, Covid-19 Vaccine Response and recent demonstrated deployment / experience within Cell and Gene Therapy is of the highest importance. To increase the U.K. capacity for GMP clinical vector manufacturing using the Catapult process to allow for expansion of U.K. skills and training within the GTIMC space and increase partnerships with other academia which will create a fertile ecosystem for innovation and research excellence in this field across academia.",
"amendments": [
{
"id": "1",
"description": "**PLEASE NOTE - THIS CONTRACT AWARD NOTICE WAS ISSUED IN ERROR AND IS A DUPLICATE OF 2022/S 000-004634.**"
}
]
},
"awards": [
{
"id": "002231-2022-1",
"relatedLots": [
"1"
],
"status": "active",
"suppliers": [
{
"id": "GB-FTS-41963",
"name": "Complete Technical Solutions Limited"
}
]
},
{
"id": "004634-2022-1",
"relatedLots": [
"1"
],
"status": "active",
"suppliers": [
{
"id": "GB-FTS-41963",
"name": "Complete Technical Solutions Limited"
}
]
},
{
"id": "005055-2022-1",
"relatedLots": [
"1"
],
"status": "active",
"suppliers": [
{
"id": "GB-FTS-41963",
"name": "Complete Technical Solutions Limited"
}
]
}
],
"parties": [
{
"id": "GB-FTS-613",
"name": "UNIVERSITY OF SHEFFIELD",
"identifier": {
"legalName": "UNIVERSITY OF SHEFFIELD"
},
"address": {
"streetAddress": "Western Bank",
"locality": "SHEFFIELD",
"region": "UKE32",
"postalCode": "S102TN",
"countryName": "United Kingdom"
},
"contactPoint": {
"name": "Jamie Shaw",
"telephone": "+44 1142221516",
"email": "jamie.shaw@sheffield.ac.uk"
},
"roles": [
"buyer"
],
"details": {
"url": "https://www.sheffield.ac.uk",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "BODY_PUBLIC",
"description": "Body governed by public law"
},
{
"scheme": "COFOG",
"id": "09",
"description": "Education"
}
]
}
},
{
"id": "GB-FTS-41963",
"name": "Complete Technical Solutions Limited",
"identifier": {
"legalName": "Complete Technical Solutions Limited"
},
"address": {
"locality": "Manchester",
"region": "UKD36",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "sme"
}
},
{
"id": "GB-FTS-41964",
"name": "High Court of England, Wales & Northern Ireland",
"identifier": {
"legalName": "High Court of England, Wales & Northern Ireland"
},
"address": {
"locality": "London",
"countryName": "United Kingdom"
},
"roles": [
"reviewBody"
]
},
{
"id": "GB-FTS-614",
"name": "High Court of England, Wales and Northern Ireland",
"identifier": {
"legalName": "High Court of England, Wales and Northern Ireland"
},
"address": {
"locality": "London",
"countryName": "United Kingdom"
},
"roles": [
"reviewBody"
]
}
],
"buyer": {
"id": "GB-FTS-613",
"name": "UNIVERSITY OF SHEFFIELD"
},
"contracts": [
{
"id": "002231-2022-1",
"awardID": "002231-2022-1",
"status": "active",
"value": {
"amount": 370000,
"currency": "GBP"
},
"dateSigned": "2022-01-25T00:00:00Z"
},
{
"id": "004634-2022-1",
"awardID": "004634-2022-1",
"status": "active",
"dateSigned": "2022-01-16T00:00:00Z"
},
{
"id": "005055-2022-1",
"awardID": "005055-2022-1",
"status": "active",
"dateSigned": "2022-01-16T00:00:00Z"
}
],
"language": "en",
"bids": {
"statistics": [
{
"id": "3",
"measure": "bids",
"relatedLot": "1",
"value": 1
},
{
"id": "1",
"measure": "lowestValidBidValue",
"relatedLot": "1",
"value": 280125,
"currency": "GBP"
},
{
"id": "2",
"measure": "highestValidBidValue",
"relatedLot": "1",
"value": 370000,
"currency": "GBP"
},
{
"id": "6",
"measure": "bids",
"relatedLot": "1",
"value": 1
},
{
"id": "4",
"measure": "lowestValidBidValue",
"relatedLot": "1",
"value": 280124,
"currency": "GBP"
},
{
"id": "5",
"measure": "highestValidBidValue",
"relatedLot": "1",
"value": 370000,
"currency": "GBP"
}
]
}
}